Skip to main content

Table 1 Attributes and levels in the treatment-choice questions

From: Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism

Attribute

Attribute label

Levels

Probability of optimal laboratory values

Chance that the treatment keeps your labs within their recommended ranges

▪ 80 out of 100 (80%)

▪ 60 out of 100 (60%)

▪ 25 out of 100 (25%)

Probability of symptom relief

Chance that the treatment relieves your SHPT symptoms

▪ 75 out of 100 (75%)

▪ 35 out of 100 (35%)

▪ 5 out of 100 (5%)

Risk of hypocalcemia

Risk of low blood calcium

▪ 0 out of 100 (0%)

▪ 2 out of 100 (2%)

▪ 10 out of 100 (10%)

Severity of nausea and vomiting

Nausea and vomiting (medication alternatives only)

▪ None

▪ Mild

▪ Moderate

Mode of administration

How you receive the medicine (medication alternatives only)

▪ Given through dialysis line during your regular dialysis treatment

▪ Pill once a week

▪ Pill once a day

Cost

Out-of-pocket cost of treatment

▪ $50 per month (medication alternatives only)

▪ $100 per month (medication alternatives only)

▪ $200 per month (medication alternatives only)

▪ $500 one time (surgery only)

  1. SHPT secondary hyperparathyroidism